Mitsubishi Heavy Industries
7011
FUJI Media Holdings
4676
SoftBank
9434
4
Nippon Telegraph & Telephone
9432
5
SoftBank Group
9984
JP Stock MarketDetailed Quotes
4884 Kringle Pharma
- 1106
- -66-5.63%
20min DelayMarket Closed Jan 23 15:30 JST
7.56BMarket Cap-9.36P/E (Static)
1151High1094Low139.00KVolume1150Open1172Pre Close154.90MTurnover132852wk High2.84%Turnover Ratio6.84MShares39452wk Low-118.21EPS TTM5.42BFloat Cap1780Historical HighLossP/E (Static)4.90MShs Float394Historical Low-118.21EPS LYR4.86%Amplitude--Dividend TTM3.57P/B100Lot Size--Div YieldTTM
Kringle Pharma Key Stats
EPS
According to the latest financial report of Kringle Pharma, the latest earnings per share (TTM) for the company is -30.68. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about Kringle Pharma's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Kringle Pharma shows that the company's current ratio is 14.68, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Kringle Pharma, the quick ratio is 12.56, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of Kringle Pharma? The latest ROE figure is -8.40%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Kringle Pharma, the total asset return on investment (ROA) is -6.83%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Kringle Pharma's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Kringle Pharma, the net profit margin is -808.30%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...